MENU
IMRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immuneering (IMRX) Earnings Date & Reports

Immuneering Corp is a biopharmaceutical company... Show more

A.I. Advisor
published Earnings

IMRX is expected to report earnings to fall 15.52% to -49 cents per share on May 13

Immuneering IMRX Stock Earnings Reports
Q1'25
Est.
$-0.49
Q4'24
Missed
by $0.13
Q3'24
Beat
by $0.06
Q2'24
Beat
by $0.05
Q1'24
Beat
by $0.01
The last earnings report on March 20 showed earnings per share of -57 cents, missing the estimate of -44 cents. With 86.46K shares outstanding, the current market capitalization sits at 53.83M.
View a ticker or compare two or three
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
245 Main Street
Phone
+1 617 500-8080
Employees
68
Web
https://www.immuneering.com